Features

24 Nov 08

We are facing a world where microbes once again have the potential to cause untreatable diseases, due to the resistance to virtually all available drugs. WHO suggests that even if the pharmaceutical industry were to step up the efforts to develop new drugs immediately, some diseases might still not have any effective therapies within the next ten years.
Visiongain

19 Nov 08

It takes courage to invest €300 million in a production site during a time of financial turmoil”,pointed out Karl-Ludwig Kley, Executive Board Chairman of the pharmaceutical company Merck Serono, this week.
Olwen Glynn Owen

17 Nov 08

The global pain market generated total sales of $34bn in 2007 – but what will the figures be in the next 5 and 10 years? This report tells you. The pain market has marked strengths and advantages, but is also limited by problems and concerns.
Suvitha Damodaran - Visiongain - Ltd

14 Nov 08

White paper from CERAM highlights novel techniques to expose fake medicines and unlicensed manufacturing processes
Mandy Rymill - CERAM

14 Nov 08

The UK’s success as a global centre of biomedical excellence is under threat in the long-term. A new report by the Association of the British Pharmaceutical Industry (ABPI) has highlighted serious concerns about the supply of skills that support the research and development of new medicines.
Editor

14 Nov 08

The global addiction market is significantly undervalued. The world’s population has a large unmet need for addiction therapy drugs. Are you ready for the opportunities this presents?
Suvitha Damodaran - Visiongain Ltd

10 Nov 08

The gastrointestinal (GI) disorders market has been one of the largest and most profitable therapeutic areas in the world pharmaceutical industry. With a reported $49.9bn in revenues in 2007, the GI disorders market competes consistently with cardiovascular diseases and oncology for the top 3 therapeutic areas in terms of market value.
Suvitha Damodaran - Visiongain

04 Nov 08

There is great potential for the women’s reproductive disorders therapeutics market – can you maximise your company’s potential in this growing market?
Andres Arias - Visiongain

04 Nov 08

NHS Direct estimate that one in five UK women over forty years of age suffer from stress incontinence and, whilst it is often caused by childbirth or menopause, it can affect any women at any age.
Sian Rees

03 Nov 08

Recent reports state that between four and five percent of the population suffer from Dyslexia. It is estimated that there are about 375,000 pupils in the UK with dyslexia and a total of some two million people who are severely affected. Yet it still can be difficult for parents to find the right help for their children.
Editor

31 Oct 08

Scientists have discovered the two key processes that allow cancer cells to change the way they move in order to spread through the body, reports leading scientific journal 'Cell'
Editor

31 Oct 08

Procter & Gamble Pharmaceuticals (P&GP) acknowledges the publication of the new Technology Appraisal Guidance (TAG 160, for the primary prevention, and 161 for the secondary prevention, of osteoporotic fragility fractures in post-menopausal women) issued by NICE.
Sebastian Stokes -Red Door Communications

31 Oct 08

Chemistry researchers at The University of Warwick and the John Innes Centre, have found a novel signalling molecule that could be a key that will open up hundreds of new antibiotics unlocking them from the DNA of the Streptomyces family of bacteria.
Editor

30 Oct 08

Following a strong performance in the third quarter, the Bayer Group confirms its targets for 2008. “Despite the difficult environment we expect in the fourth quarter, we are confirming our guidance for 2008 as a whole,”
Editor

30 Oct 08

The global financial crisis could seriously delay the discovery and production of many new life-saving medicines, warns a major international conference.
Editor

29 Oct 08

The following is taken from the ABPI's Press Release dated 29th October 2008
ABPI press office

24 Oct 08

Global survey shows how perceptions of healthcare professionals and patients influence treatment of bipolar disorder
Olwen Glynn Owen - Pharmiweb Field Reporter

24 Oct 08

NHS staff (in England) are making excellent progress against two key priority areas - to reduce waiting times to 18 weeks and cut Clostridium difficile (C. difficile) infections - statistics released today show.
Editor

23 Oct 08

This brand new report examines the commercial prospects for in vitro diagnostics (IVD) in the global healthcare market. Importantly, this report also covers theranostics, a fusion of drug therapy and diagnostics to optimise efficacy and safety, as well as streamlining drug development.
Editor

21 Oct 08

Boehringer Ingelheim and the search for new targeted cancer treatments
Kelly Smith - OgilvyHealthPR

20 Oct 08

The ever-evolving healthcare industry has very few constants, and the pharmaceutical sales industry is just another piece of the puzzle that is in the middle of a major transformation. For multinationals, eager to sell their drugs in different countries, juggling between scores of different languages and different laws has always proved to be a major dampener.
A. Nair

19 Oct 08

This week, organizations around the globe are working to create awareness and educate people about the signs, symptoms, treatment and prevention of one of the leading causes of death and disability––stroke. Wednesday, 29 October officially marks World Stroke Day.
Alex Young

15 Oct 08

Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share
Lilly Newroom

15 Oct 08

Data Indicate Bioabsorbable Stent Platform Has Potential to Become the Next Major Breakthrough in Interventional Treatment
Abbott Newsroom

15 Oct 08

Sales of $15.9 Billion Increased 6.4% Versus a Year Ago; EPS was $1.17 Excluding 2007 Special Items, 2008 Third-Quarter EPS Increased 10.4%*
Johnson & Johnson Newsroom

14 Oct 08

The pharmaceutical industry has often been described as counter-recessionary, the broad logic being that people will always get sick, and hence there will be a continuous demand for drugs. And whilst this may be true at a surface level, a more granular analysis would reveal dissimilarities between different segments of the industry
Paul Hartigan

13 Oct 08

The new oral antidiabetic drugs sitagliptin and vildagliptin work by boosting the guts incretin hormones GLP-1 and GIP to regulate insulin secretion following food intake and glucagon secretion when blood sugar is low.
Olwen Glynn Owen-Pharmiweb Field Reporter

10 Oct 08

Looking for a job as a pharma sales rep or in pharmaceutical marketing? The quickest way to find medical or pharma sales jobs on PharmiWeb.com is to use these quicklinks. You can refine your pharma job search on the search results page, and you can save your search for daily email alerts.
Editor

08 Oct 08

In 2007, the world market for bone metabolism disorder pharmaceuticals generated sales of over $10bn - how much of this market have you captured?
Suvitha Damodaran

08 Oct 08

Current treatments for rheumatoid arthritis (RA) are failing to control patients' pain adequately, and health care professionals are not fully addressing patients' concerns, new research suggests. At the recent Annual Congress of Rheumatology meeting (EULAR) in Paris this summer, findings of a study presented during a UCB-sponsored symposium highlighted a mismatch between perceptions of patients and professionals as to what constitutes effective management of RA
Olwen Glynn Owen - Pharmiweb Field Reporter